Does an anti-nausea pill mess with a new weight-loss drug? this study finds out.
NCT ID NCT07310563
First seen Jan 06, 2026 · Last updated May 08, 2026 · Updated 15 times
Summary
This study looked at how an anti-nausea drug (ondansetron) affects the levels of an experimental weight-loss medication (AMG 133) in the blood. It involved 59 adults who were overweight or obese. The goal was to gather information on drug interactions, not to treat or cure obesity.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CenExel Collaborative Neuroscience Research, LLC Los Alamitos
Los Alamitos, California, 90720, United States
Conditions
Explore the condition pages connected to this study.